주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
Updated : Friday, Aprill 26, 2024, 18:28
Home
Login
Sign in
한국어
National
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
Macro-Economics
Trade
Foreign Exchanges
Industries
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
Company & Stock Tracking
Market Trend & Outlook
Finance
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
Science
New Tech
Blockchain
ESG
Environment
Social
Governance
Event
Exhibitions
Conferences
People
K-Culture
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
Editorials
Contributions
Who's Who
기사검색
검색
All articles
List
Subject Type
Summary Type
Photo Type
Samsung Bioepis, Celltrion to Target US$20 Billion US Humira Similar Market
이미지기사
Industries
Jung Suk-yee
2023.07.03 09:38
IFEZA Commissioner Kim Jin-yong Speaks at ULI Korea Conference
이미지기사
National
Jasmine Choi
2023.06.29 20:48
K-Biotech Companies to Participate Significantly in BioUSA
이미지기사
Industries
Jasmine Choi
2023.06.01 10:01
Taking another good look
이미지기사
Finance
Jaewon Jeong
2023.05.23 10:47
Sales to keep climbing after bottoming out in 1Q23
이미지기사
Finance
Pyeongkuk Park
2023.05.15 16:24
GPM to normalize thanks to Remsima SC
이미지기사
Finance
Pyeongkuk Park
2023.05.09 18:30
South Korean Stock Market Showing Solid Growth
이미지기사
Finance
Jung Min-hee
2023.04.24 10:38
Forbes Lists MBK Partners’ Chairman Kim as South Korea’s Richest Man
이미지기사
Finance
Jung Min-hee
2023.04.19 14:28
Entering profit margin normalization phase on solid US prescriptions and one-off cost relief
이미지기사
Finance
Pyeongkuk Park
2023.04.10 17:42
Selecting out undervalued companies among defensive plays
이미지기사
Finance
Pyeongkuk Park
2023.04.06 16:23
South Korean New Drugs Enjoying Sales Growth in the U.S.
이미지기사
Lifestyle
Choi Moon-hee
2023.02.27 11:50
IFEZ Paving the Way for Incheon to Become a World-class City
이미지기사
National
Jung Suk-yee
2023.01.30 15:22
Celltrion Healthcare: Sound Growth Led by Remsima SC and Yuflyma
이미지기사
Finance
Park Pyeong-kuk
2023.01.16 18:16
Celltrion: Steady Growth Guaranteed in 2023
이미지기사
Finance
Park Pyeong-kuk
2023.01.16 18:12
Bio Industry: December US Prescription Data; Celltrion Group 4Q22 Earnings Preview
Finance
Park Pyeong-kuk
2023.01.16 18:09
Humira Biosimilar Market About to Open in the U.S.
이미지기사
Lifestyle
Jung Suk-yee
2022.12.13 12:28
2023 NH Macro Strategy: Opportunities Arise from Embrace of Change
Finance
Lawrence Kim
2022.11.25 14:37
2023 Outlook: Bio: It’s Time for Biotech Firms to Outshine S&P500 Healthcare Players
Finance
Park Pyeong-kuk
2022.11.23 11:04
Celltrion Healthcare: Direct Sales to Begin in US
이미지기사
Finance
Park Pyeong-kuk
2022.11.14 13:12
SK Inc. Expanding into CGT CDMO Business
이미지기사
Industries
Jung Min-hee
2022.11.01 11:38
처음
이전
이전
1
2
3
4
5
다음
다음
끝
위로
모바일버전
All articles
National
전체
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
전체
Macro-Economics
Trade
Foreign Exchanges
Industries
전체
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
전체
Company & Stock Tracking
Market Trend & Outlook
Finance
전체
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
전체
Science
New Tech
Blockchain
ESG
전체
Environment
Social
Governance
Event
전체
Exhibitions
Conferences
People
K-Culture
전체
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
전체
Editorials
Contributions
Who's Who
전체메뉴닫기